Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Life (Basel, Switzerland)|June 2, 2021
Irreversible Electroporation for Prostate CancerSean Ong, Matthew Leonardo, Thilakavathi Chengodu, et al.
BJU International|July 24, 2025
Guideline of guidelines: PSMA PET in staging newly diagnosed intermediate-risk prostate cancerJonathon Carll, Weiwei Shi, Marlon Perera, et al.
The Canadian Journal of Urology|March 9, 2026
Prostate specific membrane antigen (PSMA) as a biomarker in early and localized advanced prostate cancer: a narrative reviewJonathon Carll, Jacinta Bonaddio, Dixon Woon, et al.
BJU International|October 31, 2023
The CONFIRM trial protocol: the utility of prostate-specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancerDominic Bagguley, Laurence Harewood, Dean McKenzie, et al.
Prostate Cancer and Prostatic Diseases|May 12, 2026
Exploring the utility of artificial intelligence in identifying progression of prostate cancer during active surveillance: A systematic reviewJianliang Liu, Dixon T S Woon, Wafy Ahmad, et al.
Prostate Cancer and Prostatic Diseases|November 28, 2023
Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer-a systematic review and meta-analysisSiyu Huang, Sean Ong, Dean McKenzie, et al.
European Urology Oncology|May 7, 2025
Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate CancerJianliang Liu, Laurence Harewood, Dominic Bagguley, et al.
Pageof 1